Acute Radiation SyndromeRadiation InjuriesRadiation Injuries, ExperimentalRadioactive Hazard ReleaseRadiodermatitisRadiation DosageAntineoplastic Combined Chemotherapy ProtocolsDose-Response Relationship, RadiationSyndromeWhole-Body IrradiationRadiation-Protective AgentsRadiation PneumonitisChemotherapy, AdjuvantAntineoplastic AgentsProctitisMotion SicknessRadiation ToleranceRadiotherapyLethal Dose 50RadiometryCisplatinCombined Modality TherapyTreatment OutcomeRadiation, IonizingGamma RaysDoxorubicinBreast NeoplasmsCyclophosphamideNeoplasmsNauseaLung NeoplasmsPaclitaxelVomitingPrognosisNeoplasm StagingDrug Resistance, NeoplasmRadiationSurvival AnalysisCarboplatinDisease-Free SurvivalMedical OncologyDrug Administration ScheduleSurvival RateRadiation ProtectionTime FactorsRadiation MonitoringQuality of LifeTaxoidsFatigueNeoplasm Recurrence, LocalColorectal NeoplasmsCarcinoma, Non-Small-Cell LungProspective StudiesOvarian NeoplasmsNeoplasm MetastasisRetrospective StudiesDown SyndromeCell Line, TumorMice, Inbred C57BLMetabolic Syndrome XFluorouracilQuestionnairesNeoadjuvant TherapyDisease ProgressionRadiation OncologyFollow-Up StudiesApoptosisEtoposideRadiotherapy Dosage